Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$84.3M
| $1.08M | ﹤0.01% |
19,081
-6,884
| -27% | -$398K |
|
|
ATCO
4652
DELISTED
Atlas Corp.
ATCO
| $1.08M | ﹤0.01% |
80,679
-11,360
| -12% | -$164K |
|
|
GWB
4653
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.08M | ﹤0.01% |
32,300
-38,600
| -54% | -$1.27M |
|
4654
Vanguard Long-Term Treasury ETF
VGLT
$10.4B
| $1.07M | ﹤0.01% |
12,714
+2,469
| +24% | +$210K |
|
4655
PUT
Choice Hotels
CHH
$4.9B
| $1.07M | ﹤0.01% |
+23,800
| New | +$1.14M |
|
4656
PUT
Brink's
BCO
$4.57B
| $1.07M | ﹤0.01% |
28,900
+3,500
| +14% | +$120K |
|
4657
New Mountain Finance
NMFC
$712M
| $1.07M | ﹤0.01% |
+77,938
| New | +$1.07M |
|
4658
Public Service Enterprise Group
PEG
$36.5B
| $1.07M | ﹤0.01% |
25,600
-40,900
| -62% | -$1.8M |
|
4659
Methode Electronics
MEI
$646M
| $1.07M | ﹤0.01% |
30,639
-27,300
| -47% | -$960K |
|
|
WBT
4660
CALL
DELISTED
Welbilt, Inc.
WBT
| $1.07M | ﹤0.01% |
66,000
-7,200
| -10% | -$123K |
|
4661
iShares MSCI World ETF
URTH
$8.25B
| $1.07M | ﹤0.01% |
+14,727
| New | +$1.06M |
|
4662
PUT
Allegion
ALLE
$13.4B
| $1.07M | ﹤0.01% |
+15,500
| New | +$1.09M |
|
|
ESPR
4663
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.07M | ﹤0.01% |
77,100
-50,900
| -40% | -$577K |
|
4664
CALL
Manulife Financial
MFC
$70.9B
| $1.07M | ﹤0.01% |
+75,700
| New | +$1.03M |
|
|
BETR
4665
DELISTED
Amplify Snack Brands, Inc.
BETR
| $1.07M | ﹤0.01% |
65,900
+41,900
| +175% | +$656K |
|
4666
Blackstone Mortgage Trust
BXMT
$2.31B
| $1.07M | ﹤0.01% |
+36,200
| New | +$1.05M |
|
4667
CALL
Q2 Holdings
QTWO
$4.06B
| $1.07M | ﹤0.01% |
37,200
-14,400
| -28% | -$405K |
|
|
EWGS
4668
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
| $1.07M | ﹤0.01% |
24,088
+2,551
| +12% | +$109K |
|
|
LHCG
4669
CALL
DELISTED
LHC Group LLC
LHCG
| $1.07M | ﹤0.01% |
28,900
-400
| -1% | -$16K |
|
4670
Columbia India Consumer ETF
INCO
$234M
| $1.06M | ﹤0.01% |
+29,438
| New | +$1.04M |
|
|
HIBB
4671
PUT
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.06M | ﹤0.01% |
26,700
-6,700
| -20% | -$252K |
|
4672
Apple Hospitality REIT
APLE
$3.91B
| $1.06M | ﹤0.01% |
57,493
+38,892
| +209% | +$755K |
|
|
SCG
4673
DELISTED
Scana
SCG
| $1.06M | ﹤0.01% |
14,700
-116,285
| -89% | -$8.5M |
|
|
NILE
4674
PUT
DELISTED
Blue Nile, Inc.
NILE
| $1.06M | ﹤0.01% |
30,900
-25,400
| -45% | -$814K |
|
4675
PUT
Insmed
INSM
$25.9B
| $1.06M | ﹤0.01% |
73,200
+19,900
| +37% | +$249K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.